CPH:ZEAL

Zealand Pharma Stock

DENMARK |CO |DKK

Price
kr203.40
Change
-2.02%
Today's Range
kr203.40 - kr206.40
52-Week Range
kr165.50 - kr274.60
Market Cap
kr9.00B
Volume
141.88K

About Zealand Pharma (CPH:ZEAL)

(CPH:ZEAL) Zealand Pharma A/S, a biotechnology company, engages in the discovery and development of peptide-based medicines in Denmark. It has a portfolio of medicines in development stage focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes glepaglutide, a long acting GLP-2 analog, which is in Phase 3 clinical trials for the treatment of short bowel syndrome; and dasiglucagon, a stable glucagon analog for the treatment of severe hypoglycemia in diabetes and congenital hyperinsulinism, as well as for use in dual-hormone artificial pancreas for automated diabetes management. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; and Beta Bionics, Inc. to initiate home-use trial of the iLet bionic pancreas with dasiglucagon for autonomous bihormonal treatment of type 1 diabetes, as well as research agreement with Orbit Discovery Ltd. and Torrey Pines Institute for Molecular Studies. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.
Show more

ZEAL Stock Price

Statistics Highlights (CPH:ZEAL)

Shares Outstanding 43.36M Beta 0.85
Public Float 35.97M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 0.12% Ex-Dividend Date
Held by Institutions 55.88% IPO Date -

ZEAL Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue kr353.31M kr41.33M kr37.98M
EBITDA kr-794.07M kr-559.79M kr644.64M
Net Income kr-846.73M kr-571.54M kr581.28M
Total Assets kr1.92B kr1.60B kr1.23B
Total Cash kr860.77M kr1.08B kr860.63M
Total Debt kr kr kr
Jun 21 Mar 21 Dec 20
Revenue kr84.33M kr47.82M kr63.36M
EBITDA kr-303.20M kr-238.31M kr-352.04M
Net Income kr-296.81M kr-242.18M kr-380.55M
Total Assets kr1.92B kr2.17B kr1.92B
Total Cash kr987.78M kr1.31B kr860.77M
Total Debt kr kr kr

ZEAL Stock Price History

Zealand Pharma Annual Stock Price History

Year Open Close Change
2021 kr229.00 kr203.40 -11.18%
2020 kr231.00 kr229.00 -0.87%

Zealand Pharma Daily Stock Price History

Date Open High Low Close Change Volume
Sep 27, 2021 kr210.00 kr211.60 kr207.60 kr207.60 -0.86% 122.67K

(CPH:ZEAL) Stock Price FAQs

What is today's stock price of Zealand Pharma (CPH:ZEAL)?

  • The current stock price of Zealand Pharma (CPH:ZEAL) is kr203.40.
  • Today ZEAL stock price opened at kr206.40 after previous close of kr207.60.
  • During the day, Zealand Pharma stock quote has varied from a low of kr203.40 to a high of kr206.40.

What is Zealand Pharma's 52-week change?

  • ZEAL 52-week high stock quote is kr274.60, which is 35.00% above the current share price.
  • The Zealand Pharma (CPH:ZEAL) 52-week low stock price is kr165.50, which is 18.60% below the current share price.
  • Zealand Pharma share price volatility (52-week beta) is 0.85.

Zealand Pharma (CPH:ZEAL) FAQ

How Much is Zealand pharma Worth?

Zealand pharma's worth today based on market capitalisation is kr9.00B

How much money does Zealand pharma make?

Last quarter (ended on June 30 ,2021) Zealand pharma generated a net income of kr-296.81M, representing a 80.40% decrease compared to the same quarter a year before (ended on June 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Zealand pharma generated a net income of kr-846.73M, representing a 48.15% increase compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Zealand pharma's “Financials” Section

How much dividend does Zealand pharma Pay?

The current annualized dividend payout for ZEAL stock is kr0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Zealand pharma's "Dividend" Section

What were Zealand pharma’s last Earnings results?

For the last quarterly earnings period (ended on June 30, 2021) ZEAL reported kr-6.87 EPS for the quarter, missing the average analysts’ forecasts of kr-6.15 EPS by kr-0.72 (-11.71%).
View More Details on Zealand pharma's 'Earnings' Section

When is the next earnings date for Zealand pharma (CPH:ZEAL)?

Zealand pharma is expected to report earnings on November 10 ,2021.
View More Details on Zealand pharma's 'Earnings' Section

What is Zealand pharma’s Price to Earning (PE) ratio?

ZEAL stock also has a Price to Sales (P/S) ratio of 35.72, a Price to Book of 6.32 and Price/Earnings to Growth (PEG) of 0.31.

What is the Zealand pharma's ticker?

Zealand pharma trades on the Copenhagen stock market in Denmark under the ticker symbol "ZEAL". Zealand pharma’s stock symbol can also be displayed as "CPH:ZEAL".

Who are the owners of Zealand pharma?

Zealand pharma (CPH:ZEAL) is owned by 55.88% institutional shareholders and by 0.12% insiders. The rest is owned by the public.
Explore More Details on Zealand pharma's “Ownership” Section

Who are the key executives of Zealand pharma (ZEAL)?

Zealand pharma's key executive team includes the following managers:

  • Dr. Emmanuel Dulac Pharm.D., PharmD, Ph.D., MBA, CEO & Pres (1969)
  • Mr. Matthew Donald Dallas, Sr. VP & CFO (1975)
  • Ms. Hanne Heidenheim Bak, Sr. Project Director, R&D Operations Mang. and Employee Representative Director (1953)
  • Mr. Adam Sinding Steensberg M.D., Exec. VP of R&D and Chief Medical Officer (1974)
  • Mr. Ivan Mourits Møller, Sr. VP of Technical Devel. & Operations (1972)
  • Ms. Rie Schultz Hansen, VP of Discovery & Innovation (NA)
  • Lani Pollworth Morvan, Investor Relations & Communications Officer (NA)
  • Mr. Mads Kronborg, Head of Investor Relations & Communication (NA)
  • Søren Vitfell Keller, Head of Legal Affairs (NA)
  • Mr. Marino Garcia M.B.A., Sr. VP of Corp. & Bus. Devel. (1966)

What is Zealand pharma’s Sector & Industry Classification?

Zealand pharma (CPH:ZEAL) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Zealand pharma?

Currently the number of employees working for Zealand pharma is 360.

Where are Zealand pharma's Headquarters?

Zealand pharma (CPH:ZEAL) is headquartered in Denmark.

What are Zealand pharma's Address and Phone Number?

Zealand pharma’s mailing address is Sydmarken 11, Copenhagen, Denmark, 2860.
The company’s phone number is 45 88 77 36 00.

What is the official website for Zealand pharma?

Zealand pharma’s official website is http://www.zealandpharma.com